Discount Investment Corporation Ltd.

About The Fund

Discount Investment Corporation Ltd., operating through its venture capital arm, Broadview Ventures, focuses on accelerating the development of promising technology in the cardiovascular and stroke space. Their investment thesis revolves around impact investing, specifically aiming to facilitate the diagnosis and treatment of cardiovascular diseases and stroke by making targeted investments. They have built a diversified portfolio across various technologies with a vision to bring novel therapeutic options and improve patient outcomes in high unmet need populations. Their investments span innovative companies like Alveron Pharmaceuticals, which is developing anticoagulant reversal agents, and Cardiosense, which is leveraging a physiological waveform AI platform to develop predictive biomarkers for cardiovascular disease. Broadview's portfolio includes a mix of clinical-stage and preclinical companies such as Comanche Biopharma, CorFlow, IsomAb, Nyra Medical, Puzzle Medical Devices, RapidPulse, Relief Cardiovascular, and XII Medical, among others. Each portfolio company is focused on unique treatments or diagnostics, ranging from novel drug therapies, specialized medical devices, to advanced digital health platforms. They strive to address conditions like congestive heart failure, preeclampsia, ischemic diseases, pulmonary hypertension, and obstructive sleep apnea. Broadview Ventures demonstrates a commitment to fostering innovation that caters to under-served areas within the healthcare sector, thereby potentially reducing morbidity, mortality, and improving the quality of life for patients globally.